Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Corporate Minority | Dead

About Jexys Pharmaceuticals

Provider of proteins. The company operates as a cell-based drug discovery company concentrating on drugs that inhibit MAP Kinase proteins. The drugs could be used in the cure of Rheumatoid Arthritis, as well as of other inflammatory diseases, and cardiovascular diseases. [Keyword: biopharmaceutical]

Jexys Pharmaceuticals Headquarter Location

Givat Ram PO Box: 39024

Jerusalem, 91390,


972 2 658 4718

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.